Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$32.32

0.53 (1.67%)

, USB

U.S. Bancorp

$43.01

0.29 (0.68%)

20:25
10/18/16
10/18
20:25
10/18/16
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Morgan Stanley (MS), consensus 63c... U.S. Bancorp (USB), consensus 84c... Reynolds American (RAI), consensus 65c... Abbott Laboratories (ABT), consensus 58c... Halliburton (HAL), consensus (7c)... BB&T (BBT), consensus 71c... Canadian Pacific (CP), consensus $2.17... St. Jude Medical (STJ), consensus $1.01... Amphenol (APH), consensus 68c... Northern Trust (NTRS), consensus $1.09... Genuine Parts (GPC), consensus $1.29... Seagate Technology (STX), consensus 79c... Tupperware Brands (TUP), consensus 80c... UniFirst (UNF), consensus $1.23... SUPERVALU (SVU), consensus 10c.

MS

Morgan Stanley

$32.32

0.53 (1.67%)

USB

U.S. Bancorp

$43.01

0.29 (0.68%)

RAI

Reynolds American

$47.27

0.02 (0.04%)

ABT

Abbott

$41.17

0.58 (1.43%)

HAL

Halliburton

$47.07

0.75 (1.62%)

BBT

BB&T

$37.89

0.46 (1.23%)

CP

Canadian Pacific

$153.43

3.08 (2.05%)

STJ

St. Jude Medical

$79.44

1.78 (2.29%)

APH

Amphenol

$63.21

0.16 (0.25%)

NTRS

Northern Trust

$70.95

0.68 (0.97%)

GPC

Genuine Parts

$96.35

-1.48 (-1.51%)

STX

Seagate

$35.34

0.33 (0.94%)

TUP

Tupperware Brands

$64.57

0.25 (0.39%)

UNF

UniFirst

$130.80

-0.3 (-0.23%)

SVU

Supervalu

$5.02

-0.28 (-5.28%)

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 26

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 17

    Nov

  • 17

    Nov

  • 12

    Dec

MS Morgan Stanley
$32.32

0.53 (1.67%)

07/13/16
07/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Citi (C) initiated with a Buy, JPMorgan (JPM) initiated with a Sell, Goldman Sachs (GS) and Morgan Stanley (MS) initiated with a Hold at Berenberg. 2. Ingersoll-Rand (IR) initiated with an Outperform at BMO Capital. 3. Incyte (INCY) initiated with an Outperform at RBC Capital. 4. Williams (WMB) reinstated with a Buy at Goldman. 5. E-Trade (ETFC) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/16
BREN
07/13/16
INITIATION
Target $29
BREN
Hold
Morgan Stanley initiated with a Hold at Berenberg
Target $29.
06/01/16
06/01/16
NO CHANGE

BMO Capital recommends pair trade ahead of CCAR
BMO Capital recommends that investors go long Discover (DFS) and Morgan Stanley (MS) and short Comerica (CMA) and Fifth Third (FITB) ahead of the release of the 2016 CCAR results. BMO says that, after analyzing the stress tests criteria, it prefers banks with less asset sensitivity, limited exposure to capital markets, limited exposure to business outside the U.S., low market expectations for pay-out ratio increases, and high starting capital ratios. For investors expecting an intreest rate hike in June, BMO recommends going long SunTrust (STI) and shorting Comerica and Fifth Third.
10/06/16
SDLR
10/06/16
DOWNGRADE
Target $33
SDLR
Hold
Morgan Stanley downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded Morgan Stanley to Hold citing relative share outperformance and maintained his $33 price target on shares.
USB U.S. Bancorp
$43.01

0.29 (0.68%)

04/26/16
DBAB
04/26/16
DOWNGRADE
DBAB
Hold
U.S. Bancorp downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O-Connor downgraded U.S. Bancorp to Hold saying the company's earnings momentum has stalled and that it can't currently acquire other banks.
06/27/16
RBCM
06/27/16
NO CHANGE
RBCM
Some banks have reached attractive entry points, says RBC Capital
RBC Capital believes that banks may be hurt by the Fed's decision to delay raising interest rates in the wake of Brexit, and the firm admits that ucertainty regarding the EU membership of other countries could hurt U.S. banks going forward. However, the firm adds that "a silver lining" could be a boost to banks' fixed income businesses. Additionally, the firm thinks that the 10% decline in the shares of some banks "seems to be a bit premature," with the valuation of a number of banks falling to "low levels." It recommends that investors buy the following bank stocks: lBB&T (BBT), Huntington Bancshares (HBAN), JPMorgan (JPM), KeyCorp (KEY), M&T Bank (MTB), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB). The firm adds that "risk oriented investors should look to buy" Bank of America (BAC) and Citi (C).
07/06/16
BARD
07/06/16
NO CHANGE
BARD
Too early to buy the dip in bank stocks if rates stay this low, says Baird
Baird analyst David George said that lower reinvestment rates for securities should pressure net interest margin and earnings outlooks at banks and he recommends waiting until bank stocks reflect a greater discount for credit/recession risk before getting more aggressive in the space. While some management teams may choose to shrink balance sheets rather than reinvest at record-low yields, consensus earnings estimates in the sector should "trend meaningfully lower," George tells investors. Big banks among those covered by Baird include Bank of America (BAC), JPMorgan (JPM), U.S. Bancorp (USB) and Wells Fargo (WFC).
10/06/16
WEDB
10/06/16
INITIATION
Target $46
WEDB
Neutral
U.S. Bancorp initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated U.S. Bancorp with a Neutral and a $46 price target.
RAI Reynolds American
$47.27

0.02 (0.04%)

09/13/16
09/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chevron (CVX) initiated with an Outperform at BMO Capital. 2. AB InBev (BUD) initiated with a Buy at Jefferies. 3. Altria Group (MO) and Reynolds American (RAI) were initiated with a Buy at Citi while the firm initiated Philip Morris (PM) with a Neutral. 4. Under Armour (UA) initiated with a Neutral at Nomura. 5. Xerox (XRX) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
09/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Starbucks (SBUX) initiated with a Buy at Longbow. 2. Boston Beer (SAM) initiated with an Outperform at William Blair. 3. Altria Group (MO) was initiated with a Hold at Jefferies while the firm initiated Reynolds American (RAI) with a Buy. 4. Dick's Sporting (DKS) initiated with a Neutral at Guggenheim. 5. E-Trade (ETFC) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
JEFF
09/21/16
INITIATION
Target $61
JEFF
Buy
Reynolds American initiated with a Buy at Jefferies
Jefferies analyst Owen Bennett started Reynolds American with a Buy rating and $61 price target.
09/13/16
SBSH
09/13/16
INITIATION
Target $72
SBSH
Buy
Altria Group initiated with a Buy at Citi
Citi analyst Adam Spielman started Altria Group (MO) with a Buy rating and $72 price target. The analyst expects domestic demand for cigarettes is "likely to remain robust. Spielman prefers shares of Altria and Reynolds American (RAI) to Philip Morris (PM). He initiated this morning Reynolds with a Buy rating and Philip Morris with a Neutral.
ABT Abbott
$41.17

0.58 (1.43%)

09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.
HAL Halliburton
$47.07

0.75 (1.62%)

10/14/16
FBRC
10/14/16
NO CHANGE
Target $58
FBRC
Outperform
Halliburton named new Alpha Generator pick at FBR Capital
FBR Capital analyst Thomas Curran replaced Independence Contract Drilling (ICD) with Halliburton (HAL) as his Alpha Generator pick. The analyst believes Halliburton offers a superior risk/reward over the next 6-9 months and upped his price target for the stock to $58 from $53. Curran keeps an Outperform rating on the shares.
10/03/16
SOCG
10/03/16
UPGRADE
SOCG
Buy
Halliburton upgraded to Buy from Hold at Societe Generale
10/03/16
10/03/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dow Chemical (DOW) and DuPont (DD) were upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar citing he opportunity presented by the proposed merger. 2. Freeport McMoRan (FCX), Barrick Gold (ABX), and Pan American Silver (PAAS) were upgraded to Buy from Hold at Deutsche Bank. 3. LogMeln (LOGM) upgraded to Overweight from Equal Weight at Barclays with analyst Raimo Lenschow saying the pending merger with Citrix's (CTXS) divested GoTo assets creates a "great new opportunity." 4. Halliburton (HAL) upgraded to Buy from Hold at Societe General. 5. Coty (COTY) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying she believes Coty is at the beginning of a potential transformation with the pending closure of the P&G Beauty deal this week that could bring increased scale as well as a more targeted operational structure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/16
DADA
10/18/16
NO CHANGE
DADA
Halliburton results to beat expectations, says DA Davidson
DA Davidson analyst Sonny Randhawa expects Halliburton's Q3 results to beat expectations, due to its market share gains and the recovery of the North American rig count. The analyst expects the company to benefit from "higher service intensity" in coming quarters. Randhawa keeps a Buy rating on the stock.
BBT BB&T
$37.89

0.46 (1.23%)

07/11/16
BARD
07/11/16
DOWNGRADE
BARD
Neutral
BB&T downgraded to Neutral from Outperform at Baird
10/11/16
FBRC
10/11/16
DOWNGRADE
Target $40
FBRC
Market Perform
BB&T downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Steve Moss downgraded BB&T to Market Perform after assuming coverage of the name from Paul Miller. He lowered his price target for the shares to $40 from $45. Moss expects BB&T's loan growth to be pressured by softer demand and competition.
06/29/16
SDLR
06/29/16
DOWNGRADE
Target $37
SDLR
Hold
BB&T downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Stephen Scouten downgraded BB&T to Hold after lowering his 2016 and 2017 estimates to reflect higher expense run-rate and a slightly lower NIM. The analyst has a $37 price target for the shares.
07/22/16
SPHN
07/22/16
DOWNGRADE
SPHN
Equal Weight
BB&T downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Terry McEvoy noted that BB&T shares have outperformed other high-quality super regional banks by more than double year-to-date, but he sees this move as "fundamentally accurate." However, as a softer revenue environment offsets some of BB&T's expense success and with the potential for "some buyers' discount" to creep into the stock 6 as the market speculates on the timing and size of the bank's next deal, McEvoy cut the firm's rating on the stock to Equal Weight.
CP Canadian Pacific
$153.43

3.08 (2.05%)

08/04/16
08/04/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. LendingClub (LC) initiated with a Perform at Oppenheimer. 2. uniQure (QURE) assumed with a Buy at H.C. Wainwright. 3. Sunworks (SUNW) initiated with a Buy at Chardan. 4. CSX ( CSX), Canadian Pacific (CP), Norfolk Southern (NSC), and Union Pacific (UNP) initiated with a Hold, and Kansas City Southern (KSU) initiated with a Buy at Loop Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/16
SBSH
09/13/16
NO CHANGE
Target $170
SBSH
Buy
Rails remain attractive into year-end, says Citi
Citi analyst Christian Wetherbee says he continues to view railroads as the most attractive sector within Transportation into year-end and early 2017. Rail volumes could flatten and begin to turn modestly positive by the end of 2016, which would likely extend investor rotation into the space, Wetherbee tells investors in a research note. He believes valuations in the rails sector remain attractive and that 2017 estimates are achievable. Wetherbee raised his price target for Canadian Pacific (CP) to $170 from $154, for Canadian National (CNI) to $66 from $61, for CSX (CSX) to $32 from $29, for Kansas City Southern (KSU) to $110 from $109, for Norfolk Southern (NSC) to $97 from $87 and for Union Pacific (UNP) to $106 from $100. He has Buy ratings on Canadian Pacific, CSX, Kansas City Southern and Union Pacific.
10/17/16
RAJA
10/17/16
DOWNGRADE
RAJA
Outperform
Canadian Pacific downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Steve Hansen downgraded Canadian Pacific to Outperform to reflect valuation.
10/11/16
VERT
10/11/16
INITIATION
VERT
Buy
Canadian Pacific initiated with a Buy at Vertical Research
Vertical Research analyst Brian Konigsberg initiated Canadian Pacific with a Buy and a C$85 price target.
STJ St. Jude Medical
$79.44

1.78 (2.29%)

08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
APH Amphenol
$63.21

0.16 (0.25%)

06/24/16
RBCM
06/24/16
NO CHANGE
RBCM
Amphenol, Broadcom, CDW should be bought on weakness, says RBC Capital
RBC Capital says that Amphenol (APH), Broadcom (AVGO), and CDW (CDW) all have positive catalysts and have all "been able to navigate macro and micro issues successfully" in the past. The firm says that Amphenol's stock should be boosted by its organic growth and mobile ramps in 2H16, while Broadcom should benefit from the release of iPhone 7 and CDW should be boosted by the expansion of its partnership with Dell,
09/20/16
RBCM
09/20/16
NO CHANGE
RBCM
Amphenol should beat 2H16 expectations, says RBC Capital
RBC Capital analyst - Amit Daryanani says that there are "a host of positive data points" which indicate that Amphenol's 2H16 results will beat expectations. He keeps an Outperform rating on the shares.
09/20/16
GSCO
09/20/16
UPGRADE
Target $70
GSCO
Buy
Amphenol upgraded to Buy from Neutral at Goldman
Goldman analyst Mark Delaney upgraded Amphenol to Buy and raised its price target to $70 from $60. The analyst believes Amphenol's diversified customers and end markets has enabled the company to outgrow peers and its broad product mix of connectors and sensors positions it to continue to outperform the industry. Delaney expects continued solid execution and returns, and positive consensus revisions, combined with improved supply chain datapoints for Apple (AAPL) will be a catalyst for shares
03/14/16
GSCO
03/14/16
DOWNGRADE
Target $57
GSCO
Neutral
Amphenol downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Mark Delaney downgraded Amphenol to Neutral citing the recent outperformance of the shares. The analyst raised his price target for the name to $57 from $54.
NTRS Northern Trust
$70.95

0.68 (0.97%)

06/28/16
SBSH
06/28/16
UPGRADE
Target $66
SBSH
Neutral
Northern Trust upgraded to Neutral from Sell at Citi
Citi analyst Keith Horowitz upgraded Northern Trust to Neutral citing valuation following the recent underperformance of bank stocks. The analyst keeps a $66 price target for the shares.
06/28/16
06/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on the today's top five analyst upgrades with this list compiled by The Fly: 1. Dick's Sporting Goods (DKS) upgraded to Conviction Buy from Buy at Goldman by analyst Stephen Tanal, who said closure of the Sports Authority stores shortly after the July 15 sale hearing should boost investor confidence in the shares. Dick's is best positioned to benefit from store closures. He noted that his $53 price target represents 28% upside from current levels. 2. SolarCity (SCTY) upgraded to Outperform from Market Perform at Avondale, which added it to the Conviction List in anticipation of a successful resolution to Tesla's (TSLA) acquisition bid for the company. 3. Olin Corp. (OLN) upgraded to Outperform from Market Perform at Cowen by analyst Charles Neivert, who increased his price target to $31 from $18. The analyst raised 2017 EBITDA estimates above consensus to reflect reduced Dow transaction integration risks and synergies that may be more valuable than assumed. Neivert believes operational synergies for Olin could be over $300M, versus $250M guidance, reducing earnings' reliance on caustic soda price increases. 4. Northern Trust (NTRS) upgraded to Neutral from Sell at Citi by analyst Keith Horowitz, citing valuation following the recent underperformance of bank stocks. The analyst keeps a $66 price target for the shares. 5. British American Tobacco (BTI) upgraded to Conviction Buy from Sell at Goldman by analyst Fulvio Cazzol, citing increased confidence in the company's growth outlook amid the pound weakness and higher growth from e-cigarettes. The analyst raised his price target for the shares to 5185p from 3620p. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/07/16
GSCO
07/07/16
DOWNGRADE
Target $71
GSCO
Neutral
Northern Trust downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Alexander Blostein downgraded Northern Trust to Neutral saying equity market weakness and renewed rate pressures are likely to stall the company's earnings momentum. The analyst views the risk/reward as more balanced at current levels. He cut his price target for the shares to $71 from $82.
GPC Genuine Parts
$96.35

-1.48 (-1.51%)

07/15/16
JEFF
07/15/16
DOWNGRADE
Target $112
JEFF
Hold
Genuine Parts downgraded to Hold from Buy at Jefferies
Jefferies analyst Bret Jordan downgraded Genuine Parts Company to Hold with the stock close to his unchanged price target of $112. The analyst views the shares as fairly valued at current levels.
08/25/16
SUSQ
08/25/16
INITIATION
Target $102
SUSQ
Neutral
Genuine Parts initiated with a Neutral at Susquehanna
Susquehanna analyst Ali Faghri initiated Genuine Parts with a Neutral and $102 price target.
07/14/16
GABE
07/14/16
DOWNGRADE
GABE
Hold
Genuine Parts downgraded to Hold from Buy at Gabelli
Gabelli analyst Brian Sponheime downgraded Genuine Parts to Hold based on recent price appreciation.
07/14/16
07/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wynn (WYNN) Resorts downgraded to Neutral from Overweight at JPMorgan with analyst Joseph Greff saying the shares look fairly valued following the year-to-date rally. 2. Eaton (ETN) downgraded to Neutral from Buy at BofA/Merrill with analyst Andrew Obin citing valuation and balanced risk/reward. 3. Lionsgate (LGF) downgraded to Market Perform from Outperform at Bernstein with the firm saying it thinks that the Starz (STRZA) acquisition exposes Lionsgate to the portion of the entertainment market that "is in structural decline." 4. Genuine Parts (GPC) downgraded to Hold from Buy at Gabelli with analyst Brian Sponheime citing recent price appreciation. 5. Brocade (BRCD) downgraded to Underperform from Neutral at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
STX Seagate
$35.34

0.33 (0.94%)

10/11/16
10/11/16
UPGRADE
Target $43

Strong Buy
Follow-up: Seagate upgraded to Strong Buy from Buy at Needham
As previously reported, Needham upgraded Seagate to Strong Buy and raised its price target to $43 from $39. Analyst Richard Kugele said Seagate is benefiting from a generally stable to improving demand environment at the very time the company is restructuring its capacity and OPEX model for the changing environment dominated by CSPs and high-capacity drives. He believes investors will be beneficiaries of these dynamics as they flow through Seagate's model
10/11/16
BTIG
10/11/16
NO CHANGE
BTIG
Seagate weakness a buying opportunity, says BTIG
10/11/16
BNCH
10/11/16
UPGRADE
BNCH
Buy
Seagate upgraded to Buy from Hold at Benchmark
10/12/16
BMUR
10/12/16
NO CHANGE
Target $50
BMUR
Buy
Seagate gross margin model remains underappreciated, says Brean Capital
Brean Capital analyst Ananda Baruah believes the Street is underestimating Seagate's gross margin model. The analyst also said Seagate is ahead of schedule for getting back to delivering normalized earnings, free cash flow generation, and duopoly characteristics. Baruah reiterated his Buy rating and raised his price target to $50 from $42 on Seagate shares.
TUP Tupperware Brands
$64.57

0.25 (0.39%)

02/24/16
KEYB
02/24/16
NO CHANGE
KEYB
Overweight
Tupperware filing delay not about accounting issues, says KeyBanc
KeyBanc said it believes Tupperware's 10-K filing delay is not due to accounting issues and they think the 10K will be filed within the next 15 days. The firm has an Overweight rating on Tupperware shares.
02/26/16
KEYB
02/26/16
DOWNGRADE
KEYB
Sector Weight
Tupperware Brands downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Jason Gere downgraded Tupperware Brands to Sector Weight saying he sees little upside to the low end of the company's fiscal year organic sales guidance. Gere does not find the stock's risk/reward attractive over the next 12 months.
01/28/16
01/28/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Azure Midstream Partners (AZUR) downgraded at Stifel... Chesapeake (CHK) downgraded to Hold from Buy at Wunderlich... CorEnergy (CORR) downgraded at Stifel... DCP Midstream (DPM) downgraded to Hold from Buy at Stifel... DynCorp (DCP) downgraded at Stifel... Ericsson (ERIC) downgraded on challenging outlook at BMO Capital... H&E Equipment (HEES) downgraded to Neutral from Buy at UBS... Halcon Resources (HK) downgraded to Hold from Buy at Wunderlich... InvenSense (INVN) downgraded to Market Perform from Outperform at Barrington... Invitae (NVTA) downgraded to Market Perform from Outperform at Leerink... Kirby (KEX) downgraded to Sector Perform from Outperform at RBC Capital... MEG Energy (MEGEF) downgraded to Equal Weight from Overweight at Barclays... Metro (MTTRY) downgraded to Underweight from Neutral at JPMorgan... OSI Systems (OSIS) downgraded to Hold following Q2 miss at BB&T... Oasis Petroleum (OAS) downgraded to Hold from Buy at Wunderlich... Pan American Silver (PAAS) downgraded to Market Perform from Outperform at FBR Capital... Qualcomm (QCOM) downgraded to Market Perform from Outperform at William Blair... Range Resources (RRC) downgraded to Equal Weight from Overweight at Barclays... Rockwell Automation (ROK) downgraded to Underperform from Market Perform at Bernstein... Royal Gold (RGLD) downgraded to Market Perform from Outperform at FBR Capital... SEI Investments (SEIC) downgraded to Underperform at Keefe Bruyette... SandRidge Energy (SD) downgraded to Sell from Hold at Wunderlich... Seadrill (SDRL) downgraded to Equal Weight from Overweight at Morgan Stanley... ServiceNow (NOW) downgraded to Neutral from Buy at MKM Partners... State Bank Financial (STBZ) downgraded to Hold from Buy at Sandler O'Neill... Sunoco Logistics (SXL) downgraded at Stifel... Tallgrass Energy GP (TEGP) downgraded to Hold from Buy at Stifel... Tallgrass Energy (TEP) downgraded to Hold from Buy at Stifel... Textron (TXT) downgraded to Hold from Buy at Drexel Hamilton... TripAdvisor (TRIP) downgraded to Underperform from Market Perform at Raymond James... Tupperware Brands (TUP) downgraded to Neutral from Overweight at Piper Jaffray... U.S. Steel (X) downgraded to Hold from Buy at Argus... United Rentals (URI) downgraded to Neutral from Buy at UBS... Welltower (HCN) downgraded to Hold from Buy at Evercore ISI... Western Gas Partners (WES) downgraded to Hold from Buy at Stifel... Whiting Petroleum (WLL) downgraded to Hold from Buy at Wunderlich.
01/28/16
PIPR
01/28/16
DOWNGRADE
Target $50
PIPR
Neutral
Tupperware Brands downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Stephanie Wissink downgraded Tupperware Brands to Neutral saying macro headwinds and currency moves are hurting the company's growth. Wissink cut her price target for the shares to $50 from $68 following Tupperware's Q4 results.
UNF UniFirst
$130.80

-0.3 (-0.23%)

07/01/16
BARD
07/01/16
DOWNGRADE
BARD
Neutral
UniFirst downgraded to Neutral from Outperform at Baird
12/16/15
SIDC
12/16/15
UPGRADE
Target $128
SIDC
Buy
UniFirst upgraded to Buy from Neutral at Sidoti
Sidoti upgraded UniFirst to Buy with a $128 price target due to valuation, strong balance sheet and growth.
SVU Supervalu
$5.02

-0.28 (-5.28%)

10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Wal-Mart 'starting to get its act together' in grocery, says Oppenheimer
After attending Wal-Mart's (WMT) analyst day meeting, Oppenheimer analyst Rupesh Parikh admitted he did not previously look favorably upon the company's strategy to expand into Neighborhood Market and smaller format stores, but he now sees signs that the company is "starting to get its act together in grocery." If Wal-Mart follows through with grocery price investments, it could hurt Kroger (KR), Smart & Final Stores (SFS) and Supervalu (SVU) and be an "indirect negative" for Sprouts Farmers Markets (SFM), Parikh tells investors. However, he also added that he remains confident in the ability of Kroger's management team to at least hold share.
01/14/16
01/14/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alcoa (AA) downgraded on earnings estimates outlook at Argus... Atmel (ATML) downgraded to Market Perform from Outperform at Raymond James... Belmond Ltd (BEL) downgraded to Sell from Buy at MKM Partners... BorgWarner (BWA) downgraded to Underperform from Buy at CLSA... Choice Hotels (CHH) downgraded to Sell from Neutral at MKM Partners... Discover (DFS) downgraded to Neutral from Overweight at JPMorgan... Extended Stay America (STAY) downgraded to Neutral from Buy at MKM Partners... F5 Networks (FFIV) downgraded to Underweight from Equal Weight at Barclays... GoPro (GPRO) downgraded to Equal Weight from Overweight at Barclays... Hilton (HLT) downgraded to Sell from Buy at MKM Partners... Hudbay Minerals (HBM) downgraded to Underweight from Overweight at Barclays... Hyatt (H) downgraded to Sell from Neutral at MKM Partners... Ivanhoe Mines (IVPAF) downgraded to Market Perform from Outperform at BMO Capital... LafargeHolcim (HCMLY) downgraded to Neutral from Overweight at JPMorgan... Lundin Mining (LUNMF) downgraded to Equal Weight from Overweight at Barclays... Marriott (MAR) downgraded to Neutral from Buy at MKM Partners... Morgans Hotel (MHGC) downgraded to Sell from Buy at MKM Partners... NVIDIA (NVDA) downgraded to Underweight from Equal Weight at Barclays... OMV AG (OMVKY) downgraded to Sell from Neutral at UBS... PacWest Bancorp (PACW) downgraded to Market Perform from Outperform at BMO Capital... Supervalu (SVU) downgraded to Hold from Buy at Deutsche Bank... TE Connectivity (TEL) downgraded to Neutral from Buy at Longbow... Tandem Diabetes (TNDM) downgraded to Neutral from Buy at BofA/Merrill... Tarena (TEDU) downgraded to Neutral from Outperform at Credit Suisse... Teck Resources (TCK) downgraded to Underweight from Equal Weight at Barclays... TransGlobe (TGA) downgraded to Underperformer from Sector Performer at CIBC... Ubiquiti (UBNT) downgraded to Market Perform from Outperform at Bernstein... Ventas (VTR) downgraded to Market Perform from Outperform at BMO Capital... Welltower (HCN) downgraded to Market Perform from Outperform at BMO Capital... Yamana Gold (AUY) downgraded to Equal Weight from Overweight at Barclays... Yelp (YELP) downgraded to Sell from Neutral at B. Riley.
01/14/16
TLSY
01/14/16
DOWNGRADE
TLSY
Market Perform
Supervalu downgraded to Market Perform from Outperform at Telsey Advisory
07/06/16
DBAB
07/06/16
NO CHANGE
Target $6
DBAB
Hold
Deutsche calls Marsh deal a 'nice win' for Supervalu
Deutsche Bank analyst Shane Higgins views the long-term supply agreement with Marsh Supermarkets as a "nice win" for Supervalu. The news is timely with Supervalu preparing for the separation of Save-A-Lot, Higgins tells investors in a research note. The analyst keeps a Hold rating on the shares, however, citing the "headwinds still facing the business."

TODAY'S FREE FLY STORIES

CNX

CONSOL

$21.30

-0.48 (-2.20%)

, CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

15:02
12/10/16
12/10
15:02
12/10/16
15:02
Conference/Events
CONE Midstream participates in an analyst and investor day »

Management participates…

CNX

CONSOL

$21.30

-0.48 (-2.20%)

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

, CNX

CONSOL

$21.30

-0.48 (-2.20%)

14:59
12/10/16
12/10
14:59
12/10/16
14:59
Conference/Events
CONSOL to host analyst and investor day »

Analyst and Investor Day…

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

CNX

CONSOL

$21.30

-0.48 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BG

Bunge

$73.36

-0.04 (-0.05%)

14:54
12/10/16
12/10
14:54
12/10/16
14:54
Conference/Events
Bunge to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

14:50
12/10/16
12/10
14:50
12/10/16
14:50
Conference/Events
AMD to host Summit Ridge a "Zen"-based CPU at New Horizon »

President & CEO Su…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.76

0.61 (1.22%)

14:41
12/10/16
12/10
14:41
12/10/16
14:41
Conference/Events
Arthur J. Gallagher to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NYT

New York Times

$14.10

0.15 (1.08%)

14:34
12/10/16
12/10
14:34
12/10/16
14:34
Conference/Events
Detroit Economic Club to hold a luncheon meeting »

Mark Thompson, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$27.16

0.89 (3.39%)

14:28
12/10/16
12/10
14:28
12/10/16
14:28
Conference/Events
AstraZeneca has a luncheon meeting with Philadelphia Securities Association »

Luncheon Meeting being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Feb

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.